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LARP4 is a La-related RNA-binding protein implicated
in regulating mRNA translation, which interacts with
poly(A)-binding protein (PABP). We previously identi-
fied LARP4 in an RNAi screen as one of several genes
that regulate the shape of PC3 prostate cancer cells.
Here we show that LARP4 depletion induces cell elon-
gation in PC3 cells and MDA-MB-231 breast cancer
cells. LARP4 depletion increases cell migration and
invasion, as well as inducing invasive cell protrusions
in 3D Matrigel. Conversely, LARP4 over-expression
reduces cell elongation and increases cell circularity.
LARP4 mutations are found in a variety of cancers.
Introduction of some of these cancer-associated muta-
tions, including a truncation mutant, into LARP4
enhances its effects on cell morphology. The truncation
mutant shows enhanced interaction with PABP. We
propose that LARP4 inhibits migration and invasion of
cancer cells, and that some cancer-associated mutations
stimulate these effects of LARP4. VC 2016 The Authors. Cytoskeleton
Published by Wiley Periodicals, Inc.
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Introduction
Cell migration is essential for animal development andtissue repair, and contributes to human diseases includ-
ing cancer progression [Friedl and Gilmour, 2009; Ridley,
2015]. Cell migration is initiated by extracellular cues from
neighbouring cells or the extracellular matrix. Cell migra-
tion and invasion through the extracellular matrix involves
dynamic changes to the cytoskeleton, cell–cell adhesions
and cell–matrix interaction.
Genome-wide RNA interference (RNAi) screens have
been used to identify putative actin regulators that are not
well-studied for their role in cytoskeletal dynamics. For
instance, 99 genes that affected migration of the distal tip
cells during gonadogenesis were identified in an RNAi
screen in Caenorhabditis elegans [Cram et al., 2006]. Simi-
larly, La-related protein 4 (LARP4) was identified as one of
several novel regulators of prostate cancer cell morphology
[Bai et al., 2011] based on a previous genome-wide RNAi
screen in Drosophila melanogaster [Rohn et al., 2011].
Depletion of LARP4 in PC3 prostate cancer cells resulted
in cell elongation, a phenotype similar to that of depleting
several other proteins including the Rho GTPases RhoA,
RhoU and the formin Dia1. In addition, there was an
increase in long thin protrusions containing microtubules
in LARP4-depleted cells [Bai et al., 2011].
LARPs are ancient RNA-binding proteins (RBPs) which
are expressed in all eukaryotes and are subdivided in 5 fami-
lies: LARP1, La (also known as LARP3), LARP4 (which
includes LARP4 and LARP4B in vertebrates), LARP6 and
LARP7 [Bousquet-Antonelli and Deragon, 2009]. LARPs
share a common RNA recognition unit termed the La mod-
ule, consisting of a La motif (LaM) and an adjacent RNA-
recognition motif (RRM1), first discovered in La [Alfano
et al., 2004; Bousquet-Antonelli and Deragon, 2009].
Intriguingly, despite the high sequence conservation in this
RNA recognition unit, LARPs differ significantly in their
RNA substrate discrimination. For example, whereas La
recognises specifically single-stranded (ss) 30-UUUOH
stretches, affecting maturation processes of the target RNAs
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[Kotik-Kogan et al., 2008; Bayfield et al., 2010], LARP4
has been found to bind to ss oligoA sequences [Bayfield
et al., 2010; Yang et al., 2011].
LARP4 genes are present in some protists and in all ani-
mals tested but are absent from plants and yeasts [Merret
et al., 2013]. Mammalian LARP4 (also known as LARP4A)
has affinity for poly(A) RNA, suggesting it could bind to
the poly(A) tail of mRNAs, whereas LARP4B binds to AU-
rich regions in the 3’ untranslated regions of mRNAs [Kus-
pert et al., 2015]. This implies that LARP4 and LARP4B
may have distinct functions. LARP4 and LARP4B have
also been found to interact with the poly(A)-binding pro-
tein (PABP) and with Receptor for Activated C Kinase
(RACK1), a 40S ribosome- and mRNA-associated kinase
[Coyle et al., 2009; Schaffler et al., 2010; Yang et al.,
2011], consistent with a translation-related function for
LARP4 and LARP4B. Indeed overexpression of human
LARP4 resulted in increased mRNA stability whereas
knockdown of LARP4 caused a 15-20% reduction in trans-
lation, indicating that LARP4 promotes mRNA stability
[Yang et al., 2011]. LARP4 could therefore regulate cell
morphology through its binding and translational regula-
tion of mRNAs encoding cytoskeletal regulators. Further-
more, the interaction of LARP4 with RACK1 may be
particularly relevant in this context, as RACK1 has been
reported to play a role in cell adhesion and migration [Gan-
din et al., 2013].
Here, we describe the first known cellular phenotype for
LARP4. We demonstrate that LARP4 depletion induces cell
elongation and increases cell migration speed in both PC3
prostate cancer cells and MDA-MB-231 breast cancer cells.
Depletion of LARP4 also increased invasion through extra-
cellular matrix. The catalogue of somatic mutations in can-
cer (COSMIC) reports more than 130 LARP4 mutations
in various cancer types. Five cancer-associated missense
mutations and one nonsense mutation (a protein-truncating
stop codon) were introduced into LARP4, several of which
enhanced the phenotype induced by LARP4 overexpression.
These results indicate that LARP4 regulates cancer cell mor-
phology, migration and invasion, which are key processes in
the development of cancers and other diseases.
Results
LARP4 Depletion Induces Cell Elongation
To study the effects of LARP4 on cell morphology, LARP4
was depleted by siRNA-mediated knockdown in MDA-
MB-231 breast cancer cells and PC3 prostate cancer cells,
both of which migrate predominantly as single cells and do
not express the epithelial cell-cell adhesion molecule E-
cadherin [Neve et al., 2006; Valderrama et al., 2012]. Our
previous studies describing an effect of LARP4 depletion
on PC3 cell morphology were carried out using a pool of 4
siRNAs in PC3 cells [Bai et al., 2011]. Two of these
siRNAs, LARP4-2 and LARP4-4, with good knockdown
efficiencies in both PC3 cells and MDA-MB-231 cells,
were chosen for the remaining experiments (Fig. 1A).
Depletion of LARP4 resulted in cell elongation and long
thin protrusions in both PC3 and MDA-MB-231 cells (Fig.
S1 in Supporting Information). Cell circularity was deter-
mined as a measure of cell shape: a circle has a cell circulari-
ty value of 1, whereas a line has a circularity value of 0. Cell
circularity values were reduced in LARP4-depleted cells
compared to control siRNA transfected cells (Fig. 1B), indi-
cating that LARP4 knockdown results in cell elongation.
LARP4 depletion in MDA-MB-231 cells increased cell area
as compared to control siRNA-transfected cells (Fig. 1C),
although this effect was not observed in PC3 cells. Quantifi-
cation of cell shape parameters also revealed that the deple-
tion of LARP4 in PC3 and MDA-MB-231 cells resulted in
a significant increase in cell perimeter as compared to the
control cells (Fig. 1D), consistent with the more elongated
phenotype. This result is expected based on the increase in
cell elongation and area on LARP4 depletion.
LARP4 Depletion Increases Cell Migration
To investigate whether the changes in cell morphology
caused by LARP4 depletion might affect cell migration,
LARP4 was depleted in PC3 and MDA-MB-231 cells by
siRNA-mediated knockdown, and cell migration followed.
First, a modified wound healing migration assay was carried
out, in which cells migrate into a cell-free gap created by
removing a stopper (see Materials and Methods). The
migration of LARP4-depleted PC3 cells into the cell-free
gap was significantly higher as compared to the control cells
(Fig. 2A). Second, cell migration was followed by time-
lapse microscopy (Movies S1 and S2 in Supporting Infor-
mation). By tracking the migratory paths of PC3 and
MDA-MB-231 cells (Figs. 2B and 2C) in a random motili-
ty assay, LARP4-depleted cells migrated further than con-
trol siRNA-transfected cells. LARP4 depletion resulted in a
significant increase in cell migration speed (Figs. 2D and
2E). Changes in cell morphology on LARP4 depletion
therefore correlate with an increase in migration speed.
LARP4 Mutations Do Not Affect LARP4
Localization or Impair Binding to the Poly(A)-
Binding Protein
The LARP4 gene is located on human chromosome
12q13.12. Over 130 LARP4 mutations in cancers are
reported in the COSMIC. Of these, six mutations (present
in COSMIC on 7 October 2014) were chosen that are
located in the C-terminal region of LARP4, a part of the
protein that appears to mediate interactions with protein
partners of LARP4 and LARP4B such as RACK1 and
PABP [Schaffler et al., 2010; Yang et al., 2011]. The follow-
ing amino acid substitutions, S388*, R406I, I460M,
S470L, G489V and M542R, were created in the LARP4
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cDNA by site-directed mutagenesis (Fig. S2A in Supporting
Information). To determine whether any of the mutations
affected protein localization or stability, LARP4 was overex-
pressed in PC3 cells by transfecting DNA encoding wild-
type FLAG-epitope tagged LARP4 or each of the mutant
LARP4 proteins. The WT LARP4 and mutant constructs
expressed in PC3 cells were approximately 80 kDa in size
(Fig. 3A; LARP4 has 725 amino acids). LARP4-S388* has
a stop codon instead of S388, lacks amino acids 388 to 725
and therefore had a lower molecular weight (Fig. 3A).
Fig. 1. LARP4 depletion induces cell elongation. PC3 and MDA-MB-231 cells were transfected with control siRNA or the indi-
cated siRNAs targeting LARP4. (A) Western blots showing LARP4 protein levels in PC3 cells (left panel) and MDA-MB-231 cells
(right panel), 72 h after siRNA transfection. GAPDH was used as the loading control. (B–D) Cell shape parameters, including cell
circularity (B), area (mm2; C) and perimeter (mm; D) of PC3 cells (left panels) and MDA-MB-231 cells (right panels); n5 123 (33
cells/experiment) from three independent experiments for PC3 cells, and n5 213 cells (61 cells/experiment) from three indepen-
dent experiments for MDA-MB-231 cells. Values represent the cell shape parameter of each cell as a dot and the median with 25th
and 75th percentiles; one-way ANOVA followed by Tukey’s multiple comparisons test; **P< 0.01, ****P< 0.0001.
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None of the LARP4 mutations affected protein stability. In
agreement with previous studies using HeLa cells [Yang
et al., 2011], we found that FLAG-LARP4 localizes pre-
dominantly in the cytoplasm of PC3 cells (Fig. 3B). The
LARP4 mutations tested did not alter LARP4 localization
(Fig. 3B, Fig. S2B in Supporting Information).
Two regions of LARP4 have been reported to contribute
to binding to PABP: an N-terminal PAM2 motif and a
putative PABP-binding motif (PBM) mapping between
amino acids 287 and 429 [Yang et al., 2011]. Two of the
mutants (S388* and R406I) map to the PBM, and we
therefore tested whether any of the LARP4 mutants had
altered interaction with PABP. All of the mutants co-
immunoprecipitated with PABP1, and interestingly the
LARP4-S388* truncation mutant showed stronger interac-
tion with PABP1 compared to the other mutants or wild-
type LARP4 (Fig. 3A). This is consistent with previous
results showing that some LARP4 deletion mutants lacking
the C-terminal region (e.g 1-430 and 1-504) show
increased interaction with PABP compared to wild-type
LARP4 [Yang et al., 2011], which suggests the C-terminal
region contains inhibitory sequences for PABP binding.
LARP4 Mutations Differentially Affect Cell
Shape
The effect of overexpressing wild-type LARP4 and LARP4
mutants on cell morphology was investigated in PC3 cells.
Expression of wild-type LARP4 increased cell circularity
(Fig. 3C), consistent with our observation that LARP4
depletion reduced circularity and increased elongation.
Expression of LARP4 mutants in PC3 cells resulted in an
increase in cell circularity as compared to the control GFP-
expressing cells, and all of the LARP4 mutants further
increased cell circularity compared to wild-type LARP4
(Fig. 3C). Two of the LARP4 mutants, R406I and S388*,
significantly increased cell area when compared to wild-type
LARP4, although wild-type LARP4 did not change cell
area significantly compared to control GFP-expressing cells
(Fig. 3D). The expression of all LARP4 proteins resulted in
a significant decrease in cell perimeter as compared to con-
trol cells (Fig. 3E), opposite to the effect of LARP4 deple-
tion (Fig. 1). The slight increase in cell area and decrease in
cell perimeter are consistent with LARP4 overexpression
inducing a more regular circular shape compared to control
cells. Indeed, cell circularity is proportional to cell area and
inversely proportional to the square of the perimeter (see
Materials and Methods). Overall, these data indicate that
several cancer-associated mutations in LARP4 enhance its
effects on cell shape, predominantly by reducing cell elon-
gation and increasing circularity, which would be predicted
to reduce migration and invasion based on our previous
studies with PC3 cells [Vega et al., 2011]. This suggests
that some of the mutants could be more active than wild-
type LARP4.
Fig. 2. LARP4 depletion increases cell migration. (A) PC3 cells
were transfected with a pool of LARP4 siRNA2 and LARP4
siRNA4 or control siRNA. Cells were seeded onto Matrigel-coated
wells with stoppers. After 24 h, stoppers were removed, and images
of the wells were acquired (t5 0) and 24 h later (t5 24). Values
represent the mean migration into the gap left by the stopper as a
percentage of the control6 SEM; n5 3 independent experiments
(4 technical replicates/experiment); one-tailed, two-sample t-test;
*P< 0.05. (B–E) PC3 and MDA-MB-231 cells were transfected
with control siRNA or siRNAs targeting LARP4. Images of cells,
72 h after siRNA transfection, were captured at 1 frame/10 min
for 16 h by time-lapse microscopy. (B–C) Plots show example
tracks of 20 PC3 (B) or MDA-MB-231 cells (C) from one of
three independent experiments. (D–E) Mean migration speed
(lm/min) of PC3 (D) and MDA-MB-231 cells (E); n5 88 cells
( 18 cells per experiment) from three independent experiments
for PC3 cells, and n5 142 (44 cells per experiment) from three
independent experiments for MDA-MB-231 cells. Values represent
the migration speed of each cell as a dot and the median with
25th and 75th percentiles; one-way ANOVA followed by Tukey’s
multiple comparisons test; ****P< 0.0001.
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LARP4 Depletion Promotes Invasion
Cancer cells often have different morphologies in 3D as com-
pared to 2D [Doyle et al., 2013]. In order to investigate
whether LARP4 contributes to cell elongation in 3D as well
as on 2D substrata, a 3D morphology based assay was carried
out using MDA-MB-231 cells embedded in Matrigel
[Colomba and Ridley, 2014], which is a cell-derived
extracellular matrix used to mimic the environment of
tumours [Gill and West, 2014]. The LARP4-depleted cells
had a striking elongated phenotype in Matrigel as compared
to the control siRNA transfected cells (Fig. 4A). Most
LARP4-depleted cells were highly elongated, whereas nearly
all control cells were rounded (Fig. 4B). The morphology of
LARP4-depleted cells in 3D is therefore similar to that in 2D.
Fig. 3. LARP4 and LARP4 cancer-associated mutants interact with PABP and increase cell circularity. (A) HEK293T cells were
transfected with empty pCMV2-FLAG or vectors encoding WT LARP4 or LARP4 mutants. After 24 h, cells were lysed and immu-
noprecipitated with anti-FLAG antibody-conjugated agarose beads. Immunoprecipitates and total cell lysates were immunoblotted
with the indicated antibodies. GAPDH was used as a loading control. Blots are representative of two independent experiments. (B)
Representative images for the cytoplasmic localization of LARP4 and LARP4-R406I. Cells were stained for F-actin and FLAG epi-
tope. Scale bars: 15 mm. (C–E) Cell circularity, area and perimeter of WT LARP4-expressing or LARP4 mutant-expressing cells as
compared to control GFP; n5 84 cells from three independent experiments (24 cells per experiment). Values represent the cell
shape parameter of each cell as a dot and the median with 25th and 75th percentile; one-way ANOVA followed by Tukey’s multiple
comparisons test; **P <0.01, ***P <0.001, ****P <0.0001 compared to WT-LARP4 (* in red) or to control (* in black). [Color fig-
ure can be viewed at wileyonlinelibrary.com]
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To test whether LARP4 affected cancer cell invasion,
PC3 cell invasion through Matrigel-coated transwells was
analysed (Fig. 5A) [Vega et al., 2011]. Approximately 3-
fold more LARP4-depleted cells invaded through the trans-
wells than control siRNA-transfected cells (Fig. 5B). This
increased invasive behaviour of LARP4-depleted cells corre-
lates with the elongated and protrusive phenotype observed
in 2D as well as in 3D.
Discussion
In this study, we show that LARP4 affects cancer cell mor-
phology, migration and invasion. The overexpression of
LARP4 increased cell circularity, whereas LARP4 depletion
resulted in cell elongation. We also found that LARP4 sup-
presses migration, as the migration speed of two cancer cell
lines that migrate predominantly as single cells, PC3 and
MDA-MB-231, increased upon LARP4 depletion. In addi-
tion to the effect of LARP4 on cancer cells in 2D, LARP4
depletion resulted in cell elongation in 3D Matrigel and
increased invasion. We therefore conclude that LARP4
alters shape, migration and invasion of PC3 and MDA-
MB-231 cancer cells.
Cancer cells often have different morphologies in pliable
3D extracellular matrices as compared with hard 2D surfa-
ces [Sahai, 2005; Doyle et al., 2013]. However, it has been
previously shown that RhoA depletion in PC3 cells resulted
in cell elongation with thin protrusions in 2D as well as 3D
environments [Vega et al., 2011]. Similarly, the morpholo-
gy of LARP4-depleted MDA-MB-231 cells embedded in a
thick layer of 3D Matrigel was similar to that in 2D: cells
had an elongated phenotype with long thin protrusions
under both conditions. The elongated phenotype of
LARP4-depleted cells with protrusions correlates with their
increased invasion. Depletion of other proteins, including
the Rho GTPases RhoA and RhoU and the formin mDia1,
induces a similar phenotype to LARP4-depleted cells, and,
similar to LARP4 depletion, RhoA knockdown increases
invasion [Bai et al., 2011; Vega et al., 2011]. On the other
hand, the increase in circularity of LARP4-overexpressing
cells resembles that of RhoC or radixin depletion, which
inhibit PC3 cell migration and/or invasion [Vega et al.,
2011; Valderrama et al., 2012]. We would therefore expect
that LARP4-overexpressing cells would have a reduced abil-
ity to migrate or invade. It is probable that LARP4 alters
cell phenotype, migration and invasion by altering the
expression of proteins that affect these processes, such as
components of Rho signaling networks [Ridley, 2015].
Our analysis of LARP4 mutants revealed that all of them
increased cell circularity compared to wild-type LARP4,
however R406I, I460M and S470L had the strongest effect.
LARP4 R406I and S388* mutants increased cell area com-
pared to wild-type LARP4. These results suggest that four
of the LARP4 cancer-associated mutations, R406I, I460M,
S470L and S388*, may affect cancer cell migration as they
Fig. 4. LARP4 depletion causes cell elongation in 3D.
MDA-MB-231 cells were transfected with control siRNA or
siRNAs targeting LARP4. (A) 3D morphology assay in Matri-
gel. 48 h after siRNA transfection, cells were embedded in
Matrigel and seeded onto Matrigel-coated 96-well plates. Exam-
ple images are shown. Scale bar: 100 lm. (B) Cells were
assigned a shape score from 0 to 3, as indicated on the image
for LARP4-2 siRNA and in the enlarged image below (Cell
elongation scoring): a score of 0 indicates a round cell and a
score of 1, 2 or 3 indicates cells with progressively longer pro-
trusions. Graph shows mean elongation scores of cells for each
condition 1/- SEM; n 53 independent experiments (4 images
per experiment per condition).
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elicit greater changes in cell shape compared to wild-type
LARP4. Since LARP4 depletion increases PC3 and MDA-
MB-231 cell elongation and migration, it can be hypothe-
sized that these LARP4 mutants may inhibit cell migration.
What might be the mechanism to explain the observed
phenotype of LARP4? None of the LARP4 mutations ana-
lysed in this study (S388*, R406I, I460M, S470L, G489V,
M542R) maps onto the RNA-binding region, which local-
izes to the protein’s N-terminal half and encompasses the
La module [Yang et al., 2011]. In addition to RNA, two
proteins, PABP and RACK1, have been identified as direct
binding partners for LARP4 and LARP4B, and we there-
fore investigated whether the LARP4 mutations affected
interaction with either of these proteins [Schaffler et al.,
2010; Yang et al., 2011]. Our mutational analysis provides
new information on LARP4 interaction with PABP: while
none of the mutations reduces PABP interaction, the trun-
cation mutant LARP4-S388* shows enhanced binding to
PABP. This indicates that the second putative PBM,
mapped previously to residues 287 to 429 [Yang et al.,
2011], maps N-terminal to S388. It will be interesting to
test whether PABP contributes to the increased cell spread
area induced by this mutant. RACK1 interaction is likely to
be within the C-terminal 430 amino acids of LARP4B, but
its site of interaction has not been defined [Schaffler et al.,
2010]. All of the LARP4 mutants appear to interact with
RACK1 (unpublished data), and thus it is unlikely that loss
of RACK1 interaction is responsible for the morphological
changes we observe. Further studies are therefore needed to
understand the basis for LARP4 responses and the effects of
some of its mutants, which may alter interactions with as-
yet-unidentified partners for LARP4.
LARP4 mutations are very rare in cancers compared to
well-known mutated genes such as K-Ras or p53. The
majority of the many somatic mutations present in each
cancer probably do not contribute significantly to cancer
development, whereas a small subset, called driver muta-
tions, confer clonal selective advantage on the cancer cells
and are selected during the evolution of cancer [Nussinov
and Tsai, 2015; Pon and Marra, 2015]. The remaining
somatic mutations that do not confer growth advantage to
cancer cells are known as passenger mutations. It may be
that the rare LARP4 mutations are passenger mutations.
However, it has recently been proposed that individual can-
cers have latent or rare driver mutations that contribute to
cancer progression [D’Antonio and Ciccarelli, 2013; Nussi-
nov and Tsai, 2015] We speculate that the LARP4 mutants
which resulted in significant changes in cancer cell mor-
phology could be rare driver mutations, contributing to
tumour progression in some human cancers, in concert
with known driver mutations.
Of the LARPs, La, LARP1 and LARP7 have also been
implicated in cancer, albeit with rather distinct mecha-
nisms. The involvement of La has been thus far associated
with its ability to interact with internal ribosome entry sites
Fig. 5. LARP4 depletion increases invasion. PC3 cells were
transfected with control siRNA or siRNAs targeting LARP4.
After 48 h, cells in 0.1% FCS containing RPMI were seeded on
the top chamber of transwells and RPMI containing 1% FCS
was added to the bottom wells. (A) Representative images of
cells that migrated to the bottom of the transwell. Cells were
fixed with 70% ethanol and stained with 0.2% crystal violet
solution. Scale bar: 100 lm. (B) Relative invasion index com-
pared to siControl; cells on the bottom of each transwell were
counted in 10 images per experiment per condition (5 images
per technical replicate), n5 3 independent experiments. Values
represent fold-increase6 SEM of invaded cells compared to
control siRNA; one-way ANOVA followed by Tukey’s multiple
comparisons test, **P <0.01.
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of genes associated with tumour onset and malignancy (e.g.
MDM2, cyclin D1) [Sommer et al., 2011a; Trotta et al.,
2003]. Interestingly, La has been reported to stimulate
migration and invasion [Sommer et al., 2011b], which is
the opposite of what we observe for LARP4. LARP1 is
overexpressed in the majority of epithelial malignancies
compared to their adjacent normal tissues [Stavraka and
Blagden, 2015]. LARP1 may act to promote cancer by its
translational regulation of 5’ terminal oligopyrimidine tract
(TOP)-containing mRNAs such as mTOR [Mura et al.,
2015]. In contrast to La and LARP1, LARP7 is lost or
mutated in a number of cancers. LARP7’s role as a tumour
suppressor is attributed to its function as an inhibitor of the
positive transcription factor P-TEFb, a cyclin-dependent
kinase required for RNA polymerase II transcription elon-
gation [Ji et al., 2014; Stavraka and Blagden, 2015].
The exact mechanism of action of LARP4 in altering
cancer cell morphology, migration and invasion is yet to be
determined. Our results suggest the intriguing possibility
that LARP4 might alter the translation of mRNAs that
include migratory regulators. Alternatively LARP4 may act
as a global RNA chaperone contributing to the stabilisation
and/or modulation of several mRNAs [Hussain et al.,
2013], and thus LARP4 depletion would alter the tran-
scriptomic profile leading to cell motility changes. In either
case, our results with LARP4 are consistent with a growing
body of evidence indicating a prominent role for RBPs in
both the development and progression of cancer [Wurth
and Gebauer, 2015].
Materials and Methods
Cell Lines and Reagents
MDA-MB-231 breast cancer cells were grown in DMEM
supplemented with 25 mM HEPES and 2 mM glutamine,
1% sodium pyruvate, 10% FCS, 100 mg/ml streptomycin
and 100 U/ml penicillin. PC3 prostate cancer cells were
cultured in RPMI containing 25 mM HEPES and 2 mM
glutamine, 10% FCS, 100 mg/ml streptomycin and 100 U/
ml penicillin. The following antibodies were used: FLAG
(F7425, Sigma-Aldrich), LARP4 (gift from Richard Mar-
aia, National Institutes of Health, Maryland), PABP1
(4992, Cell Signaling Technologies), GAPDH (MAB374,
Merck Millipore). Mouse anti-FLAG A2220 (M2, Sigma-
Aldrich) antibody bound to agarose was used for immuno-
precipitations. Secondary HRP-labeled antibodies (anti-
mouse and anti-rabbit) were from GE Healthcare. Protease
and phosphatase cocktail inhibitor tablets were from Roche
and Calbiochem.
DNA Constructs and siRNAs
pCMV2-FLAG-LARP4 (human LARP4) was a gift from
Dr. Richard Maraia, National Institutes of Health, Mary-
land. Six LARP4 point mutations reported in cancers
(Catalogue of Somatic Mutations in Cancer; 7 October
2014) were incorporated into pCMV2-FLAG-LARP4
using QuikChange II XL Site-directed mutagenesis kit
(Agilent Technologies). Primer sequences for mutagenesis
were:
S388*: 50-TGGTGGTTCAGAACACTAAACAGAGGG
CTCTGTAT-30.
R406I: 50-GTTGAACAGATATAGTTCAATAAACTTT
CCAGCTGAACGGC-30,
I460M: 50-ACGACGAGAAGATGACAGGATGTCAA
GACCTCATC-30,
S470L: 3’-TGGAGTAGGAAGTTGTCGACTTAATTT
CCGAGGTTGT-50,
G489V: 30-GTTTAAAAGGTGGAAATGGACATTC
AAGTAGTTCTTACGGTCC-50,
M542R: 50-ACTTCTGCCCAGCAACTCAATAGGA
GTACCAGTTC-30,
All siRNAs were from Sigma-Aldrich and Dharmacon
(GE Healthcare): siLARP4-1 (CAUAAGCGUUGUAUU
GUAA), siLARP4-2 (UAGGAUGUCUGAUGUUGUU),
siLARP4-3 (CAAGGGCUAGUAAGGAUUA), siLARP4-4
(GGACAGUUGAACAGAUAUA), non-silencing siControl
(UUCUCCGAACGUGUCACGU).
Transfection
For overexpression of LARP4, cells were transfected with
pEGFP-C1 or pCMV2-FLAG empty vector (controls), or
pCMV2-FLAG-LARP4 (wild-type or mutants) using Lipo-
fectamine 2000 (ThermoFisher Scientific) in growth medi-
um without antibiotics. For depletion of LARP4, cells
seeded on plates pre-coated with collagen I (50 lg/ml) were
transfected with siControl or siRNAs targeting LARP4
using Oligofectamine (ThermoFisher Scientific) in growth
medium without antibiotics. In both cases, transfection
medium was replaced with complete medium 6 h after
transfection. Of the 4 siRNAs tested, two of them with
good knockdown efficiencies, LARP4-2 and LARP4-4,
were used for further experiments.
Immunoblotting
Cells were lysed 24 h after transfecting LARP4 cDNA or
72 h after siRNA transfection in lysis buffer (50 mM Tris-
HCl, pH 8.0, 250 mM NaCl, 1% Triton X-100, 25 mM
NaF and 2 mM Na3VO4) supplemented with protease
cocktail inhibitors. Lysates were resolved in 4-12% poly-
acrylamide gels (Invitrogen, ThermoFisher Scientific),
transferred to nitrocellulose membranes and incubated with
antibodies. Membranes were blocked in 5% dried milk
powder in Tris-buffered saline with 0.1% Tween-20 (TBS-
T) and incubated with the primary antibody for 16-18 h
(except GAPDH for 1 h) at 48C. Following incubation
with primary antibody, membranes were washed 3 times
with TBS-T and incubated with species-appropriate horse-
radish peroxidase-conjugated secondary antibodies.
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Immunoprecipitation
HEK293T cells were lysed 24 h after DNA transfection in
20 mM Tris-HCl (pH 8.0), 130 mM NaCl, 1% Triton X-
100, and 1 mM Dithiothreitol (DTT), supplemented with
protease and phosphatase cocktail inhibitors. After centrifu-
gation, some supernatant was kept for analysis of total
lysates, and the remaining supernatants were incubated
with anti-FLAG antibody-conjugated agarose beads (20
ll for each condition) or 2 h at 48C. The beads were
washed extensively with lysis buffer. Samples were analysed
by western blotting as described above.
Immunofluorescence and Confocal Microscopy
Cells on coverslips were fixed with 4% paraformaldehyde,
permeabilized with 0.1% Triton X-100 and blocked with
3% BSA in PBS. F-actin, DNA and microtubules were
visualized using AlexaFluor 546-conjugated phalloidin
(1:400; Molecular Probes), DAPI (1:10000; Molecular
Probes) and/or FITC-labelled anti-a-tubulin (1:1000;
Sigma-Aldrich, clone DM1A). Coverslips were mounted
onto glass slides using fluorescence mounting medium
(Dako). Images were acquired using a LSM 510 confocal
microscope (Zeiss) using a 20X objective and Zen software
(Zeiss). Images are from cells fixed 24 h after transfection
of DNA encoding LARP4 or its mutants, or 72 h after
siRNA transfection.
Cell Morphology Analysis
Morphological analysis was carried out using ImageJ
(National Institutes of Health). The edges of cells were
traced using the F-actin staining boundary. For cells trans-
fected with pCMV2-FLAG-LARP4 or its mutants,
LARP4-expressing cells/LARP4-mutant expressing cells
(detected with anti-FLAG antibody) were quantified and
compared to cells transfected with pEGFP-C1 (control).
Boundaries of cells were determined and cell shape parame-
ters including cell area, perimeter and circularity were gen-
erated using ImageJ. Circularity is calculated as
4p 3 Area
Perimeterð Þ2 ; with a value of 1 indicating a perfect cir-
cle and values closer to zero indicating an elongated pheno-
type of cells. Results were graphically represented using
GraphPad Prism 6.
Cell Migration Assays
For the modified scratch wound migration assay, PC3 cells
were transfected with a pool of LARP4 siRNA2 and
LARP4 siRNA4 or control siRNA. After 24 h, cells were
incubated with Cell Tracker Orange CMRA (1:400; Ther-
moFisher Scientific) in growth medium for 40 minutes at
378C, 5% CO2. Following incubation, the dye was
removed and cells were washed in PBS. Cells were
detached, counted and seeded at a density of 4 3 x104 cells
per well in medium containing 1% FCS in a 96 well plate
with OrisTM cell seeding stoppers (Platypus Technologies).
Wells were pre-coated with 100 lg/ml Matrigel for 1 h
(BD Biosciences). After 24 h, stoppers were removed, and
images of the wells were acquired using a Nikon TE2000-E
microscope with a Plan Fluor 4x objective (Nikon) and a
Hamamatsu Orca-ER digital camera using Volocity soft-
ware (PerkinElmer). 24 h after acquiring the initial images,
wells were imaged again in the same positions to analyse
the movement of cells into the cell-free gap. Image analysis
was carried out using ImageJ.
For random cell migration, PC3 cells were seeded at 104
cells per well on Matrigel-coated 6-well plates, and MDA-
MB-231 cells at 2 3 104 cells per well on collagen I-coated
24-well plates. Cells were starved in medium containing
0.1% FCS, 48 h after siRNA transfection. After a further
24 h, the medium was replaced with medium containing
1% FCS, immediately before the start of the migration
assay. Images were acquired for 16 h at 1 frame/10 min at
378C using a 10X/0.3 NA Plan Fluor objective on a Nikon
TE-2000 time lapse microscope with a Hamamatsu Orca-
ER camera and Volocity (for PC3 cells) or Micro-Manager
software (for MDA-MB-231 cells). Images were acquired
from at least two wells each for control siRNA, LARP4-2
and LARP4-4. Cells were tracked using ImageJ (Plugin:
Manual tracking) to obtain migration speed (lm/min).
Cells that died, divided, or moved out of the frame were
excluded from the analysis and tracking. The path of each
cell was obtained as a track using ImageJ (Plugin: Chemo-
taxis tool).
Position-to-position and well-well migration parameters
were compared to check if the data for each condition were
consistent within each experiment and between three differ-
ent experiments. There were no significant variations
between the technical replicates or experimental replicates
of each condition indicating that the three independent
experiments were consistent.
3D Morphology Assay
Flat bottom plates (96-well) were coated with 7.5 mg/ml
Matrigel and incubated at 378C for 2 h. Cells were embed-
ded in Matrigel 48 h after siRNA transfection: 5x104
MDA-MB-231 cells in DMEM without FCS were added
to wells of “V” bottom 96-well plates and mixed with 100
ml of 7 mg/ml Matrigel in DMEM without FCS. This mix-
ture was then added to the Matrigel pre-coated plates and
the Matrigel was allowed to polymerize for 2 h before
DMEM without FCS was added on the top. Plates were
incubated at 378C for 24 h.
Four random fields per well were acquired 72 h after
siRNA transfection, using a 10X/0.3 NA Plan Fluor objec-
tive on a Nikon TE-2000 time lapse microscope with a
Hamamatsu Orca-ER camera and Micro-Manager soft-
ware. Each cell was given a score of 0, 1, 2 or 3, where 0
indicates a round cell, and 1, 2 and 3 indicate cells with
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progressively longer protrusions. Out-of-focus cells were
not scored.
Transwell-Based Invasion Assay
The transwell-based BD Biocoat Invasion System (8 mm
pore diameter; BD Biosciences) was used for invasion
through a Matrigel layer. 48 h after siRNA transfection,
104 PC3 cells in medium containing 0.1% FCS were added
to the transwells and medium containing 1% FCS was used
as an attractant in the lower chamber. After 24 h, cells on
the bottom of the coated transwell were fixed with 70%
ethanol and stained with 0.2% crystal violet solution. Ran-
dom images from three independent experiments (10 per
experimental condition) were acquired using a Nikon
Eclipse TS100 microscope with a 103 objective and cells
counted using ImageJ (Plugin: Cell counter). The cells on
the bottom of each transwell were counted. For each experi-
mental condition, the total number of cells from the 10
images was divided by the total number of cells for control
siRNA-transfected cells.
Statistical Analysis
One-way analysis of variance (ANOVA) followed by
Tukey’s multiple comparisons test was used unless stated
otherwise. All plots show median with 25th and 75th per-
centiles unless stated otherwise. Statistical significance is
indicated by *P< 0.05, **P< 0.01, ***P< 0.001,
****P< 0.0001 as compared to the control unless stated
otherwise.
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